Mark S. Huberman, M.D.

Assistant Professor, Department of Medicine, Harvard Medical School

Staff, Hematology/Oncology, Beth Israel Deaconess Medical Center

Contact Info

Mark Huberman
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Mailstop: Shapiro Clinical Center, Suite 913
Phone: 617-667-9236
Fax: 617-975-5665
mhuberma@caregroup.harvard.edu

Assistant

Lauren Catanzano
Beth Israel Deaconess Medical Center
Phone: 617-667-9236
lcatanza@caregroup.harvard.edu
Theresa Medina
Administrative Assistant
Hematology/Oncology
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Phone: 617-667-9236
Fax: 617-975-5665
tmedina@bidmc.harvard.edu

DF/HCC Program Affiliation

Translational Pharmacology and Early Therapeutic Trials
Lung Cancer

Research Abstract

Research interests focus on Phase I-III clinical trials in solid tumors especially lung, esophagus, colorectal, and breast cancers. Current projects include multi-modality treatment of locally advanced lung and esophageal cancer, evaluation of matrix metallo proteinase inhibitors in lung cancer, and anticipate project evaluating EGF receptor antagonist in lung cancer Phase I Study of an outpatient regimen of recombinant human.

Publications

View All Publications

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	Mark S. Huberman, M.D. Assistant Professor, Department of Medicine, Harvard Medical School Staff, Hematology/Oncology, Beth Israel Deaconess Medical Center Contact Info Mark Huberman Beth Israel Deaconess Medical Center 330 Brookline Avenue Boston, MA, 02215 Mailstop: Shapiro Clinical Center, Suite 913 Phone: 617-667-9236 Fax: 617-975-5665 mhuberma@caregroup.harvard.edu Assistant Lauren Catanzano Beth Israel Deaconess Medical Center Phone: 617-667-9236 lcatanza@caregroup.harvard.edu Theresa Medina Administrative Assistant Hematology/Oncology Beth Israel Deaconess Medical Center 330 Brookline Avenue Boston, MA, 02215 Phone: 617-667-9236 Fax: 617-975-5665 tmedina@bidmc.harvard.edu DF/HCC Program Affiliation Translational Pharmacology and Early Therapeutic Trials Lung Cancer Research Abstract Research interests focus on Phase I-III clinical trials in solid tumors especially lung, esophagus, colorectal, and breast cancers. Current projects include multi-modality treatment of locally advanced lung and esophageal cancer, evaluation of matrix metallo proteinase inhibitors in lung cancer, and anticipate project evaluating EGF receptor antagonist in lung cancer Phase I Study of an outpatient regimen of recombinant human. Publications View All Publications
Site Map Site Feedback Web Privacy Policy